Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial

NCT00001146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

NIH

Sponsor class

Conditions

Bipolar Disorder
Involutional Depression
Mood Disorder

Interventions

DRUG: Ethyl Eicosapentaenoic Acid
DRUG: OmegaBrite

Sponsor

National Institute of Mental Health (NIMH)